Results
1 -
10 of
20
(Click
here to explore results)
- New Frontiers in Chemical Biology: Enabling Drug Discovery, Chapter 3 Targeted Intracellular Protein Degradation as a Potential Therapeutic Strategy. A.R. Schneekloth, C.M. Crews
, 2011
, Pages 64-96
- Peptide-based Drug Discovery: Challenges and New Therapeutics, CHAPTER 11 Development of Peptide-Based Diagnostic and Therapeutic Agents in Oncology. Kamala Kesavan
, 2017
, Pages 326-363
- Ion Mobility-Mass Spectrometry: Fundamentals and Applications, CHAPTER 15 Conformational Characterisation of Biomolecules. Ruth Knox, Alexey Barkhanskiy, Aidan P. France, Perdita E. Barran
, 2022
, Pages 402-435
- Protein–Protein Interaction Regulators, CHAPTER 10 Small-molecule Modulators of Protein–Protein Interactions: Focus on 14-3-3 PPIs. L. Iralde-Lorente, M. Botta, C. Ottmann
, 2021
, Pages 249-279
- Anti-fibrotic Drug Discovery, CHAPTER 6 Targeting the Ubiquitin Proteasome System in Pulmonary Fibrosis. Andrew J. Thorley, Simon Krautwald, David J. Rowlands
, 2020
, Pages 165-184
- Protein–Protein Interaction Regulators, CHAPTER 11 Discovery of AMG 232, a Small Molecule MDM2 Inhibitor in Clinical Development and its Back-up Clinical Candidate, AM-7209. Yosup Rew, John Eksterowicz
, 2021
, Pages 280-301
- Drug Design Strategies: Quantitative Approaches, Chapter 15 The Impact of Genomics, Systems Biology, and Bioinformatics on Drug and Target Discovery: Challenge and Opportunity. Darren R. Flower
, 2012
, Pages 397-439
- Protein Degradation with New Chemical Modalities: Successful Strategies in Drug Discovery and Chemical Biology, Chapter 1 PROTAC-mediated Target Degradation: A Paradigm Changer in Drug Discovery?. Philipp M. Cromm, Craig M. Crews, Hilmar Weinmann
, 2020
, Pages 1-13
- Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles, Chapter 10 α-Helix Mimetics as Inhibitors of Protein–Protein Interactions. A. J. Wilson
, 2021
, Pages 305-335
- Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles, Chapter 2 Target-based Screening and Structure-based Design Approaches to Develop Modulators of Protein–Protein Interactions. Ashley E. Modell, Paramjit S. Arora
, 2021
, Pages 40-65